Study of a virus treatment delivered into liver arteries
Treatments studied
Part of Cancer clinical trials.
This Phase 1 study tests an oncolytic (tumor-attacking) virus given directly into liver arteries using a catheter. It’s for people with advanced liver cancer who have already tried standard treatments or can’t have them, aiming to assess safety and early anti-cancer activity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You agree to the study and sign informed consent before any study procedures
- You are 18–75 years old, and you have liver cancer (primary or spread) confirmed by lab tests
- Your cancer has not responded to standard treatment, or you can’t or don’t want standard treatment
- Your overall performance status is 0 or 1, and your liver function is Child-Pugh A or B
- Your blood counts and organ tests are within allowed ranges on labs done within 7 days before treatment
- If you have hepatitis B or C, you must be on the right antiviral treatment and meet liver-function requirements
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests a virus therapy designed to attack solid tumors that cannot be removed by surgery or have returned/spread. It may help shrink tumors and control cancer in people whose standard treatments are no longer working.
This trial tests combining a special virus injected directly into the tumor with two approved drugs (tislelizumab and lenvatinib) for advanced liver cancer that hasn't been treated before. The goal is to see if this triple approach can shrink tumors and improve outcomes.
This early-phase trial tests a cancer-killing virus (OTS-412) that is injected directly into tumors. It is for people with solid tumors that have not responded to standard treatments, including immunotherapy. The goal is to see if the virus can shrink or control the injected tumors.
This study tests whether a special virus injected directly into tumors can help your body fight cancer when combined with an immunotherapy drug. It is for people with advanced colorectal, stomach, or liver cancer that has spread and who have tumors that can be reached for injection.
This study tests a combination of treatments for people with advanced liver cancer that has spread. The therapy uses a virus to attack the tumor and drugs to boost the immune system, which may help shrink the cancer or slow its growth.
This trial tests a virus-based treatment for people with advanced solid tumors that haven't responded to standard treatments. The virus is designed to infect and kill cancer cells while leaving healthy cells alone.
Hear when a new Advanced Liver Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.